Pfizer Unveils New San Francisco-Based Biotech Center, R&D Leaders
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm names Global R&D-VP Martin Mackay to succeed LaMattina, taps former Merck exec to head clinical development.
You may also be interested in...
Pfizer’s New Org Chart Brings Eight Wyeth Execs Topside
In a move designed to allay concerns about post-Wyeth integration challenges, Pfizer outlined on April 7 the leadership structure of the future entity
Pfizer’s New Org Chart Brings Eight Wyeth Execs Topside
In a move designed to allay concerns about post-Wyeth integration challenges, Pfizer outlined on April 7 the leadership structure of the future entity
Pfizer Drafts A New “Org Chart” Post Wyeth Merger
Pfizer to appoint a number of key Wyeth execs to prominent positions post-merger, sending a clear signal that it is handling the integration of Wyeth differently from its previous acquisitions of Pharmacia and Warner Lambert.